Ascendis Pharma (ASND) PT Lowered to $165 at JPMorgan
Tweet
Share
E-mailGet Alerts ASND Hot Sheet
Price: $268.03 +0.27%
Rating Summary:
23 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 16 | New: 22
Rating Summary:
23 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 16 | New: 22
Join SI Premium – FREE
JPMorgan analyst Jessica Fye lowered the price target on Ascendis Pharma (NASDAQ: ASND) to $165.00 (from $174.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Ascendis Pharma (ASND) PT Raised to $312 at Oppenheimer
- Ascendis Pharma (ASND) PT Lowered to $273 at Morgan Stanley
- CLSA Upgrades Taiyo Yuden Co Ltd (6976:JP) (TYOYY) to High-Conviction Outperform (1)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
